trending Market Intelligence /marketintelligence/en/news-insights/trending/_bP8xpL4cEHcpeRFkGFohA2 content esgSubNav
In This List

Unichem Laboratories settles US FDA concerns at Indian facility

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Unichem Laboratories settles US FDA concerns at Indian facility

Unichem Laboratories Ltd. settled concerns raised by the U.S. Food and Drug Administration following an inspection of the company's Ghaziabad facility in India.

The company received an establishment inspection report from the regulator, indicating the successful closure of inspection points raised by the FDA body following an inspection between Feb. 24 and March 3.